System News

Friday, March 25, 2022 - New cancer drug approved with support of Roper St. Francis Healthcare

Roper St. Francis Healthcare had more patients than anywhere else in the world enrolled in the clinical trial of Opdivo, which recently was approved by the federal Food and Drug Administration to treat lung cancer.

Dr. Gene Saylors with Charleston Oncology served as lead investigator for the trial.

Watch the story on Live 5 News.

Back to Top
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our Digital Privacy Policy.